Exploring the potential function of high expression of ANAPC1 in regulating ubiquitination in hepatocellular carcinoma

doi:10.4251/wjgo.v17.i5.103594

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1403)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-10) series.

Item

Count

PDF

HTML

746

Figures (1-10)

202

Sum=1004

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

280

Sum=333

May 15, 2025 (publication date) through Aug 13, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. May 15, 2025; 17(5): 103594
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103594

Full Size Figure Download Figure

Figure 10 Relationship between ANAPC1 expression levels and tyrosine kinase inhibitors drug effects. A: Sorafenib; B: Dasatinib; C: Ibrutinib; D: Lapatinib; E: Nilotinib; F: Afatinib. Ic50: Half maximal inhibitory concentration.

Citation: Tang YX, Wu WZ, Zhou SS, Zeng DT, Zheng GC, He RQ, Qin DY, Huang WY, Chen JT, Dang YW, Tang YL, Chi BT, Zhan YT, Chen G. Exploring the potential function of high expression of ANAPC1 in regulating ubiquitination in hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(5): 103594
URL: https://www.wjgnet.com/1948-5204/full/v17/i5/103594.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.103594